Author

A. Baudry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Llibre· 1 shared A.-S. Korganow· 1 shared B. Bader-Meunier· 1 shared B. Beitz· 1 shared B. Schneider· 1 shared B. Terrier· 1 shared D. Duffy· 1 shared J.-P. Herbeuval· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Llibre

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the chemokine receptor CXCR4 with histamine analogue to reduce inflammation in juvenile arthritis: a proof of concept for COVID-19 therapeutic approach

N. Bekaddour, N. Smith, B. Beitz, A. Llibre, T. Dott, A. Baudry, A.-S. Korganow, S. Nisole, R. Mouy, S. Breton, B. Bader-Meunier, D. Duffy, B. Terrier, B. Schneider, P. Quartier, , J.-P. Herbeuval

This study shows that targeting CXCR4 with clobenpropit reduces inflammation in juvenile arthritis and COVID-19 by lowering cytokine levels and immune cell activity.

bioRxiv · Oct 24, 2021 · PreprintImmunology